---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-164443"
form_type: "8-K"
ticker: "IOBTQ"
cik: "0001865494"
company_name: "IO Biotech, Inc."
filed_at: "2023-06-09T23:59:59+00:00"
generated_at: "2026-06-14T04:19:45.603566+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# IO Biotech shareholders elect directors and approve officer exculpation amendment at annual meeting

## Summary
- Priyanka Belawat and Christian Elling elected as Class II directors until 2026 annual meeting.
- Amendment to Certificate of Incorporation to provide officer exculpation approved: 20,021,960 for, 115,161 against.
- Ratification of EY Godkendt Revisionspartnerselskab as independent auditor for FY2023 approved: 20,815,596 for, 111,302 against.
- Broker non-votes were 789,675 on director elections and the exculpation proposal.

## SEC filing metadata
- accession: 0001193125-23-164443
- form_type: 8-K
- ticker: IOBTQ
- cik: 0001865494
- company_name: IO Biotech, Inc.
- filed_at: 2023-06-09T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1865494/000119312523164443/0001193125-23-164443-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1865494/000119312523164443/d457839d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-164443
- JSON: https://secwatch.observer/filing/0001193125-23-164443.json
- Plain text: https://secwatch.observer/filing/0001193125-23-164443.txt

## Key facts
- Shareholder Votes
  IO Biotech, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2023-06-08 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-08
  source text: Proposal Three: Ratification of Appointment of Independent Registered Public Accounting Firm The stockholders ratified the appointment of EY Godkendt Revisionspartnerselskab as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 by the following vote: For Against Abstain Broker Non-Votes 20,815,596 111,302 4,683 —
  evidence_url: https://www.sec.gov/Archives/edgar/data/1865494/000119312523164443/0001193125-23-164443-index.htm
- Shareholder Votes
  IO Biotech, Inc. shareholders approved Election of Class II Directors at the 2023-06-08 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-08
  source text: Proposal One: Election of Class II Directors Each of Priyanka Belawat and Christian Elling was elected to serve as a class II director to hold office until the Company’s 2026 Annual Meeting of Stockholders and until the election and qualification of his or her successor. Votes were cast as follows: For Withheld Broker Non-Votes Priyanka Belawat, Ph.D. 18,148,150 1,993,756 789,675 Christian Elling, Ph.D. 18,139,833 2,002,073 789,675
  evidence_url: https://www.sec.gov/Archives/edgar/data/1865494/000119312523164443/0001193125-23-164443-index.htm
- Shareholder Votes
  IO Biotech, Inc. shareholders approved Amendment to the Certificate of Incorporation to Provide Exculpation for Officers at the 2023-06-08 meeting.
  - Proposal: charter amendment
  - Outcome: passed
  - Meeting: 2023-06-08
  source text: Proposal Two: Amendment to the Certificate of Incorporation to Provide Exculpation for Officers The stockholders approved an amendment to the Company’s Certificate of Incorporation to provide exculpation for officers by the following vote: For Against Abstain Broker Non-Votes 20,021,960 115,161 4,875 789,675
  evidence_url: https://www.sec.gov/Archives/edgar/data/1865494/000119312523164443/0001193125-23-164443-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.